Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 72 entries
View as:

A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02595034 Org: User:
Start: 01/31/15 End: 11/30/15 Due: 11/30/16

A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT01742663 Org: User:
Start: 10/31/12 End: 10/31/13 Due: 10/31/14

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea

Phase: N/A Priority: Normal
NCT ID: NCT03689010 Org: User:
Start: 12/12/17 End: 09/28/18 Due: 09/28/19

To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03427554 Org: User:
Start: 08/21/17 End: 01/26/18 Due: 01/26/19

A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis

Phase: N/A Priority: Normal
NCT ID: NCT01519752 Org: User:
Start: 11/30/11 End: 11/30/12 Due: 11/30/13

Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis Study

Phase: N/A Priority: Normal
NCT ID: NCT01043393 Org: User:
Start: 02/28/10 End: 06/30/10 Due: 06/30/11

Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT04134273 Org: User:
Start: 03/20/19 End: 10/15/19 Due: 10/15/20

Pilot Efficacy Study of T2000 in Myoclonus Dystonia

Phase: N/A Priority: Normal
NCT ID: NCT00506012 Org: User:
Start: 08/31/07 End: 10/31/11 Due: 10/31/12

A Study of T2000 in Essential Tremor

Phase: N/A Priority: Normal
NCT ID: NCT00321087 Org: User:
Start: 08/31/06 End: 12/31/07 Due: 12/31/08

Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS

Phase: N/A Priority: Normal
NCT ID: NCT02933528 Org: User:
Start: 07/11/16 End: 11/27/17 Due: 11/27/18

A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%

Phase: N/A Priority: Normal
NCT ID: NCT03257943 Org: User:
Start: 03/20/17 End: 08/18/17 Due: 08/18/18

Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02411942 Org: User:
Start: 08/31/14 End: 02/28/15 Due: 02/28/16

Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis

Phase: N/A Priority: Normal
NCT ID: NCT01580891 Org: User:
Start: 05/31/12 End: 07/31/13 Due: 07/31/14

Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02618759 Org: User:
Start: 08/28/15 End: 08/25/17 Due: 08/25/18

Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02595073 Org: User:
Start: 09/04/15 End: 08/29/17 Due: 08/29/18

Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice

Phase: N/A Priority: Normal
NCT ID: NCT00927472 Org: User:
Start: 08/31/09 End: 06/30/10 Due: 06/30/11

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

Phase: N/A Priority: Normal
NCT ID: NCT02932878 Org: User:
Start: 09/02/16 End: 10/16/17 Due: 10/16/18

Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02709902 Org: User:
Start: 09/30/15 End: 03/31/16 Due: 03/31/17

A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02578043 Org: User:
Start: 04/30/15 End: 09/30/15 Due: 09/30/16

Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice

Phase: N/A Priority: Normal
NCT ID: NCT00291057 Org: User:
Start: 02/28/06 End: 12/31/06 Due: 12/31/07

Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice

Phase: N/A Priority: Normal
NCT ID: NCT00963508 Org: User:
Start: 08/31/09 End: 03/31/10 Due: 03/31/11

Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice

Phase: N/A Priority: Normal
NCT ID: NCT00927407 Org: User:
Start: 07/31/09 End: 08/31/09 Due: 08/31/10

Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice

Phase: N/A Priority: Normal
NCT ID: NCT00752973 Org: User:
Start: 09/30/08 End: 01/31/12 Due: 01/31/13

Efficacy Study in Patients With Acne Vulgaris.

Phase: N/A Priority: Normal
NCT ID: NCT02935036 Org: User:
Start: 10/03/16 End: 03/21/17 Due: 03/21/18

Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis

Phase: N/A Priority: Normal
NCT ID: NCT02335255 Org: User:
Start: 06/27/14 End: 05/15/18 Due: 05/15/19